HEXAOM (ALHEX.PA) Stock Fundamental Analysis

EPA:ALHEX • FR0004159473

35 EUR
-0.5 (-1.41%)
Last: Feb 19, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALHEX. ALHEX was compared to 33 industry peers in the Household Durables industry. ALHEX has an average financial health and profitability rating. ALHEX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ALHEX had positive earnings in the past year.
  • In the past year ALHEX has reported a negative cash flow from operations.
  • ALHEX had positive earnings in 4 of the past 5 years.
  • In the past 5 years ALHEX always reported a positive cash flow from operatings.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • ALHEX has a Return On Assets of 1.46%. This is comparable to the rest of the industry: ALHEX outperforms 54.55% of its industry peers.
  • With a Return On Equity value of 3.94%, ALHEX perfoms like the industry average, outperforming 51.52% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.70%, ALHEX perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 9.70%.
  • The 3 year average ROIC (8.77%) for ALHEX is well above the current ROIC(3.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.46%, ALHEX is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALHEX has declined.
  • ALHEX's Operating Margin of 2.30% is on the low side compared to the rest of the industry. ALHEX is outperformed by 60.61% of its industry peers.
  • In the last couple of years the Operating Margin of ALHEX has declined.
  • ALHEX has a worse Gross Margin (21.14%) than 81.82% of its industry peers.
  • In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

4

2. Health

2.1 Basic Checks

  • ALHEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ALHEX has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ALHEX has been reduced compared to a year ago.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALHEX has an Altman-Z score of 2.15. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALHEX has a Altman-Z score (2.15) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.40 indicates that ALHEX is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.40, ALHEX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACC0.52
WACC7.14%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ALHEX has a Current Ratio of 1.31. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.31, ALHEX is in line with its industry, outperforming 42.42% of the companies in the same industry.
  • A Quick Ratio of 0.99 indicates that ALHEX may have some problems paying its short term obligations.
  • ALHEX has a better Quick ratio (0.99) than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

  • ALHEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.84%.
  • ALHEX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.22% yearly.
  • ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.53%.
  • The Revenue has been decreasing by -9.93% on average over the past years.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • Based on estimates for the next years, ALHEX will show a very strong growth in Earnings Per Share. The EPS will grow by 37.93% on average per year.
  • Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.72, ALHEX can be considered very expensive at the moment.
  • ALHEX's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of ALHEX to the average of the S&P500 Index (27.09), we can say ALHEX is valued inline with the index average.
  • A Price/Forward Earnings ratio of 8.71 indicates a reasonable valuation of ALHEX.
  • Based on the Price/Forward Earnings ratio, ALHEX is valued a bit cheaper than the industry average as 69.70% of the companies are valued more expensively.
  • ALHEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.98.
Industry RankSector Rank
PE 26.72
Fwd PE 8.71
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALHEX is valued a bit cheaper than the industry average as 60.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.6
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ALHEX's earnings are expected to grow with 37.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.95
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.35%, ALHEX has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.76, ALHEX has a dividend in line with its industry peers.
  • ALHEX's Dividend Yield is slightly below the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 1.35%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

HEXAOM

EPA:ALHEX (2/19/2026, 7:00:00 PM)

35

-0.5 (-1.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)N/A
Inst Owners15.33%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap242.90M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86.67
Price Target46.41 (32.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.35%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)16.67%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26.72
Fwd PE 8.71
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 2.4
EV/EBITDA 6.6
EPS(TTM)1.31
EY3.74%
EPS(NY)4.02
Fwd EY11.48%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)10.95
PEG (5Y)N/A
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.15
F-Score4
WACC7.14%
ROIC/WACC0.52
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALHEX.PA.


What is the valuation status for ALHEX stock?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


How profitable is HEXAOM (ALHEX.PA) stock?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

The Price/Earnings (PE) ratio for HEXAOM (ALHEX.PA) is 26.72 and the Price/Book (PB) ratio is 1.06.


Can you provide the financial health for ALHEX stock?

The financial health rating of HEXAOM (ALHEX.PA) is 4 / 10.